Obstetrics & Gynecology Doctors in Gary, IN Accepting Medicare

5 Obstetrics & Gynecology doctors found. Showing 1 - 5

Michael A Linton, MD Obstetrics & Gynecology - Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2269 W 25th Ave, Gary, IN 46404 Phone: 219-944-4187    Fax: 219-944-4196

Ana Davette Perry, MD Obstetrics & Gynecology - Gynecology Medicare: Medicare Enrolled Practice Location: 600 Grant St, Gary, IN 46402 Phone: 601-532-0689

Anthony O Iwuagwu, M.D. Obstetrics & Gynecology - Gynecology Medicare: Medicare Enrolled Practice Location: 2200 Grant St, Ste 207, Gary, IN 46404 Phone: 219-944-7565    Fax: 219-944-1304

Dr. Otito Nnebundo Aronu, M.D Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2269 W 25th Ave, Gary, IN 46404 Phone: 219-944-4187    Fax: 219-944-4196

Arnita Reed, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2269 W 25th Ave, Gary, IN 46404 Phone: 219-944-4187    Fax: 219-944-4196

News Archive

IDM Pharma plans to amend NDA for Mifamurtide (L-MTP-PE) for the treatment of osteosarcoma

IDM Pharma, Inc. has announced that it has recently met with the U.S. Food and Drug Administration (FDA) and informed the FDA that the Company intends to take immediate action to supplement the data in its current New Drug Application (NDA) for mifamurtide (L-MTP-PE), formerly known as Junovan, which is being reviewed for the treatment of children and adolescents with non-metastatic osteosarcoma.

Northwestern surgical oncologists use minimally invasive procedure to remove malignant melanoma

That's when she received the results from her dermatologist, who removed a part of the blister and had it tested. It turns out that little red bump was malignant melanoma, the leading cause of skin cancer death in the United States. It's a cancer that kills one person every hour, which translates to more than 8,700 Americans each year.

SBRT improves survival in patients with inoperable non-small cell lung cancer

Highly-focused stereotactic body radiation therapy (SBRT) can eliminate the targeted tumor while avoiding treatment-related illness and may ultimately improve survival for patients with inoperable non-small cell lung cancer, according to early findings of a Radiation Therapy Oncology Group study published in the March 17 cancer-themed issue of the Journal of the American Medical Association.

Symbiomix closes $41 million Series A financing and reports positive results from SYM-1219 Phase 2 trial

Symbiomix Therapeutics today announced multiple milestones, including the closing of the third and final tranche of a $41 million Series A financing and positive results from a multi-center, randomized Phase 2 trial testing a single oral dose of SYM-1219 for the treatment of bacterial vaginosis (BV).

HIV infections, deaths declining in Caribbean, senior official says

Ahead of the regional Pan Caribbean Partnership Against HIV/AIDS (PANCAP) meeting, a senior official announced that the number of new HIV infections in the region has fallen since last year, Agence France-Presse reports.

Read more Medical News

› Verified 9 days ago